Navigation Links
China Shenghuo Pharmaceutical Holdings, Inc. Announces Conference Call to Discuss Third Quarter FY 2007 Results
Date:11/13/2007

KUNMING, China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. ("China Shenghuo," "the Company") (Amex: KUN), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in the People's Republic of China ("PRC"), today announced it will conduct a conference call at 8:00 a.m. EST on Friday, November 16, 2007, to discuss the Company's financial results for the third quarter, ended September 30, of its 2007 fiscal year.

Hosting the call will be Feng Lan, Director and President, and Qionghua Gao, Chief Financial Officer.

To participate in the event by telephone, please dial (800) 291-9234 five to 10 minutes prior to the start time (to allow time for registration) and reference the conference ID 46154547. International callers should dial (617) 614-3923 and reference the same passcode.

A digital replay of the call will be available on Friday, November 16 at approximately 10:00 a.m. EST through Friday, November 23 at 12 p.m. EST. To listen to the replay, dial (888) 286-8010 and enter the conference ID number 98064518. International callers should dial (617) 801-6888 and enter the same conference ID number.

The conference call will also be webcast live over the Internet and can be accessed by all interested parties at the company's Web site, http://www.shenghuo.com.cn .

To monitor the live webcast, please visit the Company's Web site and click on the webcast link at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software. An audio replay of the event will be archived on China Shenghuo's Web site, at http://www.shenghuo.com.cn .

About China Shenghuo Pharmaceutical Holdings, Inc.

Founded in 1995, China Shenghuo Pharmaceutical Holdings, Inc. ("China
'/>"/>

SOURCE China Shenghuo Pharmaceutical Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...ivanCotter Releases Results of Fourth Annual Physi...urvey, DETROIT, July 25 /PRNewswire/ -- Sullivan,...rth annual survey of physician on-call pay rates a...y Report. The survey report,with data from 132 he...ian,on-call pay practices and rates paid for 33 ph...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begin...l/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ...ced today that its subsidiary has commenced commer...psules USP product in the 40mg,strength from its D...on,with the launch, Watson has 180 days of marketi...
(Date:7/25/2008)... McKesson Corporation Executive, Robert J. Reilly,...re/ -- Aethon Inc.,( http://www.aethon.com ), the ...supply chain logistics, today announced that Rober...President -- Chief Financial Officer., Reilly, wh...ger for,McKesson Corporation,s Specialty Pharmacy ...
(Date:7/25/2008)...STON, July 25 /PRNewswire/ -- The Elekta Family of...er treatment solutions at the 2008,American Associ...ing,demonstrating how the joint forces of Elekta,...on therapy planning and delivery solutions that,st...experience for,patients, as well as enhance clinic...
Breaking Medicine News(10 mins):Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3
... in the tsunami last year are eagerly expecting th...em to conceive again.// Despite having undergone ... district of Tamil Nadu in southern India will now...fter the successful performance of the surgery cal...
...y get, never lose their beauty - they merely move ...xbaum Jacqueline Saburido was a very normal girl w... // A tragic incident that occurred on the 19th of...met with a road traffic accident in which more tha...
...t to fight for receiving the new breast cancer dru... aggressive type of breast cancer and wants to mak...t that the disease is in its early stage has meant... to fund the treatment. Many women have already ta...
...Dr Michael Fenech studied the damage of excess alc...d that excess intake of // alcoholic beverages res... DNA. During the course of the study, six men age...w in plant phenols for two days, and then drank 30...
Other Medicine News:Health News:Recanalization enables Tsunami mourners to parent again 2Health News:The Looming Controversy Surrounding Facial Transplant 2
(Date:7/24/2008)...uly 24 /PRNewswire-USNewswire/ -- There are a reco...lnesses, according to a new,report released here t...ting effects that mental illnesses have on patient... illness affects nearly 60 million American,adults... and Manufacturers,of America (PhRMA), featured Em...
(Date:7/24/2008)...thermometer designed to take body temperature, for...Newswire-FirstCall/ --- Kidz-Med, Inc.,(subsidiary...: ASFX),United States distributor of the Thermofo...to announce the results of a clinical study,conduc...ity of Milan, in,Milan, Italy, which proves that t...
(Date:7/23/2008)...irst Approved Systemic Therapy to Treat the Diseas.../-,Bayer HealthCare Pharmac...NXX) today announced that The New England Journal ...emonstrating that Nexavar(R) (sorafenib),tablets d...in patients with,unresectable hepatocellular carci...
(Date:7/23/2008)...ly 23 /PRNewswire-USNewswire/ -- The following was...irman Conyers, Ranking Member Smith, and Members o...testify today., Since I appeared before this Comm...tter acquainted with the talented and dedicated pr... work they do, and I have come to,appreciate that ...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Incidental adrenal masses commonly seen on CT are usually benign 3B no follow up needed 19886 1Is extra corporal liver support with prometheus safe in patients with end stage liver disease 3F 19881 1Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 1Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 2Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 3Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 4Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 5Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 6Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 7Newly Approved Cimzia 28R 29 Provides Rapid Sustained Response in Crohns Patients 19876 8Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 19871 1Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 19871 2Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 19871 3
....--(BUSINESS WIRE)--May 31, 2007 - The Waismann,Me...y of Suboxone,users, indicating that 66 percent of... as Subutex or Buprenorphine, believe they,cannot ...g a,physical dependency. Suboxone is often prescri...ntin, Vicodin, Lortab or,Fentanyl. Because Suboxon...
...USINESS WIRE)--Jun 1, 2007 - A therapeutic,vaccine...state,cancer promises new hope for cancer patients... study will be presented to an,international audie...ty for Clinical Oncology (ASCO) in Chicago, USA. A...n of cancer specialists,world-wide., The active su...
Other Medicine Technology:Waismann Method Survey Reveals Dependency Risk for People Using,Suboxone 2Vakzine Projekt Management Reports Positive Clinical Trial Results,With Their Therapeutic Prostate Cancer Vaccine VPM4001 2
...ssional ophthalmic photographer. Integrated flash,...ground illumination, all controlled through a rele...stick, as well as adaptors allowing for the fittin...tal and 35 mm cameras, ensure ophthalmic imaging o...
...ltiplexing platform that uses advanced microarray ...sequence detection and pharmacogenetics applicatio...applied to an open and flexible electronic microar...ntil all tests sites have been utilized. This open...
...c laser platform, combining innovative laser deliv... fast operation, super adjustable Nd:YAG offset an...laser systems. ,The Nidek YC-1800 replaces th... the Joystick "Smart Switch" and One-Touch Lock.,...
epTIPS Filter have an integrated filter made of pure hydrophobic polyethylene without "self-sealing" additives. This filter provides protection against carryover and contamination caused by aerosols,
Medicine Products: